Based on our data we could potentially hypothesize that the binding of the peptide could disrupt the interaction of EWS-FLI1 with Nucleophosmin or peptide’s interactions with Nucleophosmin on its own effect the inhibition of tumorigenic properties of Ewing’s sarcoma cells. The gene discussed is FLI1; the disease is Ewing sarcoma.